Targeted Biopsy in Men High Risk for Prostate Cancer: 68Ga-PSMA PET/CT Versus mpMRI
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference31 articles.
1. GÖTEBORG-2 trial investigators: prostate cancer screening with PSA and MRI followed by targeted biopsy only;Hugosson;N Engl J Med,2022
2. Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging;Sheikhbahaei;Eur J Nucl Med Mol Imaging,2017
3. Diagnostic Performance and Clinical Impact of PSMA PET/CT versus mpMRI in patients with a high suspicion of prostate cancer and previously negative biopsy: a prospective trial (PROSPET-BX);Lopci;Urol Int,2023
4. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis
5. Detection rate of 68Ga-PSMA PET/CT vs. mpMRI targeted biopsy for clinically significant prostate cancer;Pepe;Anticancer Res,2022
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low- to Intermediate-Risk Prostate Cancer: A Tool to Improve Risk Stratification for Active Surveillance?;Life;2024-01-02
2. PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview;Seminars in Nuclear Medicine;2024-01
3. 68Ga-prostate specific membrane antigen-11 PET/CT versus multiparametric MRI in the detection of primary prostate cancer: A systematic review and head-to-head comparative meta-analysis;European Journal of Radiology;2024-01
4. Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Parameters Could Predict International Society of Urological Pathology Risk Groups of Prostate Cancers on Radical Prostatectomy;Life;2023-09-21
5. Current role of PSMA-PET imaging in the clinical management of prostate cancer;Therapeutic Advances in Medical Oncology;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3